**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 111-76-2 |2-Butoxyethanol | 97 | 203-905-0
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause transient corneal injury.
Skin:
Causes skin irritation. Substance is rapidly absorbed through the
skin. Causes symptoms similar to those of inhalation. May be harmful
if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May be harmful if swallowed.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. May cause respiratory tract irritation. May be harmful if
inhaled.
Chronic:
May cause liver and kidney damage. Chronic exposure may cause blood
effects. Chronic exposure may cause effects similar to those of
acute exposure.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid immediately.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Combustible liquid and
vapor. Vapors are heavier than air and may travel to a source of
ignition and flash back. Vapors can spread along the ground and
collect in low or confined areas.
Extinguishing Media:
Water may be ineffective. Do NOT use straight streams of water. For
small fires, use dry chemical, carbon dioxide, or water spray. For
large fires, use water spray, fog or regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Ground and bond
containers when transferring material. Avoid contact with eyes, skin,
and clothing. Empty containers retain product residue, (liquid and/or
vapor), and can be dangerous. Do not pressurize, cut, weld, braze,
solder, drill, grind, or expose empty containers to heat, sparks or
open flames. Keep away from heat and flame. Avoid breathing vapor or
mist.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Containers
should be dated when opened and tested periodically for the presence
of peroxides. Should crystals form in a peroxidizable liquid,
peroxidation may have occurred and the product should be considered
extremely dangerous. In this instance, the container should only be
opened remotely by professionals. All peroxidizable substances should
be stored away from heat and light and be protected from ignition
sources.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Personal Protective Equipment
Eyes:
Wear chemical goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Always use
a NIOSH or European Standard EN 149 approved
respirator when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: mild ether-like odor
pH: Not available.
Vapor Pressure: 0.88 mm Hg @ 25 deg C
Viscosity: 2.83 cS @25 deg C
Boiling Point: 171 deg C
Freezing/Melting Point: -70 deg C
Autoignition Temperature: 238 deg C ( 460.40 deg F)
Flash Point: 62 deg C ( 143.60 deg F)
Explosion Limits, lower: 1.1% @ 93C
Explosion Limits, upper: 12.7% @ 135C
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density: 0.90
Molecular Formula: C6H14O2
Molecular Weight: 118.18
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Under normal storage conditions, peroxidizable compounds can form
and accumulate peroxides which may explode when subjected to heat or
shock. This material is most hazardous when peroxide levels are
concentrated by distillation or evaporation.
Conditions to Avoid:
Ignition sources, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 111-76-2: KJ8575000
LD50/LC50:
CAS# 111-76-2: Dermal, guinea pig: LD50 = 230 uL/kg; Draize test,
rabbit, eye: 100 mg Severe; Draize test, rabbit, eye: 100 mg/24H
Moderate; Inhalation, mouse: LC50 = 700 ppm/7H; Inhalation, rat: LC50
= 450 ppm/4H; Oral, mouse: LD50 = 1230 mg/kg; Oral, rabbit: LD50 =
300 mg/kg; Oral, rat: LD50 = 470 mg/kg; Skin, rabbit: LD50 = 220
mg/kg.
Carcinogenicity:
2-Butoxyethanol -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
24-Hr. LC50; goldfish: 1650 mg/L
96-Hr. LC50; bluegill sunfish: 1490
mg/L
96-Hr. LC50; tidewater silversides: 1250 mg/L
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/38 Irritating to eyes and skin.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
S 46 If swallowed, seek medical advice immediately
and show this container or label.
WGK (Water Danger/Protection)
CAS# 111-76-2: 1
United Kingdom Occupational Exposure Limits
United Kingdom Maximum Exposure Limits
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 111-76-2 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 111-76-2: OEL-AUSTRALIA:TWA 25 ppm (120 mg/m3);Skin
OEL-AUSTRIA:TWA 20 ppm (100 mg/m3);Skin
OEL-BELGIUM:TWA 25 ppm (121 mg/m3);Skin
OEL-DENMARK:TWA 25 ppm (120 mg/m3);Skin
OEL-FINLAND:TWA 25 ppm (120 mg/m3);STEL 75 ppm (350 mg/m3);Skin
OEL-FRANCE:TWA 25 ppm (120 mg/m3);Skin
OEL-GERMANY:TWA 20 ppm (100 mg/m3);Skin
OEL-HUNGARY:TWA 100 mg/m3;STEL 200 mg/m3;Skin
OEL-THE NETHERLANDS:TWA 20 ppm (100 mg/m3);STEL 4 ppm;Skin
OEL-THE PHILIPPINES:TWA 50 ppm (240 mg/m3);Skin
OEL-POLAND:TWA 100 mg/m3
OEL-RUSSIA:STEL 5 mg/m3
OEL-SWEDEN:TWA 20 ppm (100 mg/m3);STEL 50 ppm (25 mg/m3);Skin
OEL-SWITZERLAND:TWA 20 ppm (100 mg/m3);STEL 40 ppm;Skin
OEL-TURKEY:TWA 50 ppm (240 mg/m3)
OEL-UNITED KINGDOM:TWA 25 ppm (120 mg/m3)
OEL-UNITED KINGDOM:TWA 25 ppm (120 mg/m3);Skin
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 111-76-2 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/08/1999 Revision #9 Date: 12/03/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Hepes Sodium Salt, DNase, RNase and Protease Free, 99+%
| 75277-39-3 |
|
DL-alpha-Methylbenzylisothiocyanate, 98%
| 32393-32-1 |
|
Isopropanol, DNase, RNase, Protease free
| 67-63-0 |
|
Bromobenzene, 99%
| 108-86-1 |
|
Isopropyl-??-D-thiogalactopyranoside, DNase, RNase, Protease free,
| 123-91-1 |
|
Acetic Acid, Sodium Salt, Anhydrous, DNase, RNase, Protease Free
| 127-09-3 |
|
Bromoform, 99+%, Stabil. With 1 wt.% Ethanol
| 64-17-5 |
|
Buffer Solution pH 4
| 50-00-0 |
|
Sodium chloride, DNase, RNase, Protease free
| 7647-14-5 |
|
2-Butoxyethanol, 97%
| 111-76-2 |
|
Dodecyl sulfate, sodium salt, DNase, RNase, Protease free
| 151-21-3 |
|
Tris(hydroxymethyl)aminomethane,DNase,RNase,Protease free
| 77-86-1 |
|
Triton?? X-100, DNase, RNase, Protease free, peroxides free
| 9002-93-1 |
|
Cadmium chloride hemipentahydrate, reagent ACS, crystals
| 7790-78-5 |
|
Urea, DNase RNase and Protease free
| 57-13-6 |
|
25-Ethoxycalix[4]arene
| 138240-24-1 |
|
Cadmium nitrate tetrahydrate, reagent, crystals, 99%
| 10022-68-1 |
|
(S)-(+)-Tetrahydro-5-Oxo-2-Furanecarboxylic Acid, 98%
| 21461-84-7 |
|
25,27-Dipropoxycalix[4]Arene, 95%
| 162301-48-6 |
|
25,26,27,28-Tetrapropoxycalix[4]Arene, 98%
| 0-01-1 |
|
Cadmium sulfate, 8/3-hydrate, reagent acs, crystals
| 7790-84-3 |
|
5-Bromo-25,26,27,28-Tetrapropoxycalix[4]Arene, 97%
| 0-01-1 |
|
Caffeine, 98% (Titr.)
| 58-08-2 |
|
5,11,17,23-Tetrabromo-25,26,27,28-tetrapropoxycalix[4]arene, 98%
| 181640-72-2 |
|
Calcium hydride, CA. 93%, 0-2 mm Grain size
| 7789-78-8 |
|
Acrylamide
| 79-06-1 |
|
5,11-Dibromo-25,27-Dipropoxycalix[4]arene, 99%
| 176098-88-7 |
|
25-Ethoxy-27-Diethoxyphosphoryloxycalix[4]Arene
| 0-01-1 |
|
5,11,17,23-Tetrakis-dimethylaminomethylcalix[4]arene
| 115421-52-8 |
|
Trifluoroacetylisocyanate
| 14565-32-3 |
|
C-Undecylcalix[4]resorcinarene Monohydrate
| 0-01-1 |
|
Sodium tert-Pentoxide, 95%
| 14593-46-5 |
|
2-Phenylpropyl butyrate, 98%
| 80866-83-7 |
|
Diisopropyl Azodicarboxylate, 94%
| 2446-83-5 |
|
5-Fluoroorotic Acid Hydrate, 98%
| 703-95-7 |
|
Poly-L-leucine
| 0-01-1 |
|
2-Nitrochalcone
| 7473-93-0 |
|
Calcium hydroxide, reagent ACS
| 1305-62-0 |
|
4-Methoxychalcone
| 959-33-1 |
|
Calcium lactacte pentahydrate (powder), 98% (titr.)
| 5743-47-5 |
|
Ethyl stearate, mixture 1:1 with ethyl palmitate
| 111-61-5 |
|
MOPS, DNase, RNase, Protease Free
| 1132-61-2 |
|
(R)-(+)-Carbobenzyloxyamino-3-Phenyl-1-Propanol
| 58917-85-4 |
|
Bafilomycin A1
| 88899-55-2 |
|
2,6-Dichloro-5-Fluoronicotinoyl Chloride, 90%
| 96568-02-4 |
|
Methyl Indole-4-Carboxylate
| 39830-66-5 |
|
2134800 Phosphate, dibasic, anhydrous, 97+%
| 7757-93-9 |
|
N-BOC Ethyl Oxamate
| 0-01-1 |
|
3-(4-Methylbenzoyl)Propionic Acid, 98%
| 4619-20-9 |
|
4-(4-Methylphenyl)Butyric Acid, 98%
| 4521-22-6 |
|
|